Advanced search
Publication Cover
Future Medicinal Chemistry Volume 3, 2011 - Issue 2
Submit an article Journal homepage
139
Views
1
CrossRef citations to date
0
Altmetric
Review

Gabaergic Drugs in the Treatment of Epilepsy: Modern or Outmoded?

Marco MulaDepartment of Clinical & Experimental Medicine, Division of Neurology, University Hospital Maggiore della Carità, C.so Mazzini 18, ItalyCorrespondence[email protected]
View further author information
Pages 177-182 | Published online: 11 Feb 2011

Bibliography

  • Rogawski MA , LoscherW. The neurobiology of antiepileptic drugs.Nat. Rev. Neurosci.5(7), 553–564 (2004).
  • Holtkamp M , MeierkordH. Anticonvulsant, antiepileptogenic, and antiictogenic pharmacostrategies.Cell. Mol. Life Sci.64(15), 2023–2041 (2007).
  • Meldrum BS , RogawskiMA. Molecular targets for antiepileptic drug development.Neurotherapeutics4(1), 18–61 (2007).
  • Duncan JS , SanderJW, SisodiyaSM, WalkerMC. Adult epilepsy.Lancet367(9516), 1087–1100 (2006).
  • Glauser TA . Behavioral and psychiatric adverse events associated with antiepileptic drugs commonly used in pediatric patients.J. Child Neurol.19(Suppl. 1), S25–S38 (2004).
  • Carter CRJ , KozuskaJL, DunnSMJ. Insights into the structure and pharmacology of GABAA receptors. Future Med. Chem.2(5), 859–875 (2010).
  • Rogawski MA , LoscherW. The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions.Nat. Med.10(7), 685–692 (2004).
  • Whiting PJ . The GABAA receptor gene family: new targets for therapeutic intervention. Neurochem. Int.34(5), 387–390 (1999).
  • Farrant M , NusserZ. Variations on an inhibitory theme. Phasic and tonic activation of GABAA receptors. Nat. Rev. Neurosci.6(3), 215–229 (2005).
  • Stell BM , BrickleySG, TangCY, FarrantM, ModyI. Neuroactive steroids reduce neuronal excitability by selectively enhancing tonic inhibition mediated by d subunit-containing GABAA receptors. Proc. Natl Acad. Sci. USA100(24), 14439–14444 (2003).
  • Monaghan EP , NavaltaLA, ShumL, AshbrookDW, LeeDA. Initial human experience with ganaxolone, a neuroactive steroid with antiepileptic activity.Epilepsia38(9), 1026–1031 (1997).
  • Cunningham MO , DhillonA, WoodSJ, JonesRS. Reciprocal modulation of glutamate and GABA release may underlie the anticonvulsant effect of phenytoin.Neuroscience95(2), 343–351 (2000).
  • Cunningham MO , JonesRS. The anticonvulsant, lamotrigine decreases spontaneous glutamate release but increases spontaneous GABA release in the rat entorhinal cortex in vitro.Neuropharmacology39(11), 2139–2146 (2000).
  • Deckers CL , HeksterYA, KeyserA, MeinardiH, RenierWO. Pharmacotherapy of epilepsy: state of the art and developments.J. Clin. Pharm. Ther.22(5–6), 309–322 (1997).
  • Mula M . New antiepileptic drugs: molecular targets.Cent. Nerv. Syst. Agents Med. Chem.9(2), 79–86 (2009).
  • Manning JP , RichardsDA, BoweryNG. Pharmacology of absence epilepsy.Trends Pharmacol. Sci.24(10), 542–549 (2003).
  • Bialer M , JohannessenSI, LevyRH, PeruccaE, TomsonT, WhiteHS. Progress report on new antiepileptic drugs: a summary of the Ninth Eilat Conference (EILAT IX).Epilepsy Res.83(1), 1–43 (2009).
  • Conti F , MinelliA, MeloneM. GABA transporters in the mammalian cerebral cortex: localization, development and pathological implications.Brain Res. Brain Res. Rev.45(3), 196–212 (2004).
  • Krogsgaard-Larsen P , FalchE, LarssonOM, SchousboeA. GABA uptake inhibitors: relevance to antiepileptic drug research.Epilepsy Res.1(2), 77–93 (1987).
  • Suzdak PD , JansenJA. A review of the preclinical pharmacology of tiagabine: a potent and selective anticonvulsant GABA uptake inhibitor.Epilepsia36(6), 612–626 (1995).
  • Czuczwar SJ , PatsalosPN. The new generation of GABA enhancers. Potential in the treatment of epilepsy.CNS Drugs15(5), 339–350 (2001).
  • Porter RJ . Mechanisms of action of new antiepileptic drugs.Epilepsia30(Suppl. 1), S29–S34 (1989).
  • Treiman DM . GABAergic mechanisms in epilepsy.Epilepsia42(Suppl. 3), 8–12 (2001).
  • Bialer M , JohannessenSI, KupferbergHJ, LevyRH, LoiseauP, PeruccaE. Progress report on new antiepileptic drugs: a summary of the Fifth Eilat Conference (EILAT V).Epilepsy Res.43(1), 11–58 (2001).
  • Sarup A , LarssonOM, SchousboeA. GABA transporters and GABA-transaminase as drug targets.Curr. Drug Targets CNS Neurol. Disord.2(4), 269–277 (2003).
  • Mares P , SlamberovaR. Biphasic action of vigabatrin on cortical epileptic after-discharges in rats.Naunyn Schmiedebergs Arch. Pharmacol.369(3), 305–311 (2004).
  • Wu Y , WangW, RichersonGB. Vigabatrin induces tonic inhibition via GABA transporter reversal without increasing vesicular GABA release.J. Neurophysiol.89(4), 2021–2034 (2003).
  • Mula M , TrimbleMR. Antiepileptic drug-induced cognitive adverse effects: potential mechanisms and contributing factors.CNS Drugs23(2), 121–137 (2009).
  • Stewart SA . The effects of benzodiazepines on cognition.J. Clin. Psychiatry66(Suppl. 2), 9–13 (2005).
  • Bialer M , JohannessenSI, KupferbergHJ, LevyRH, PeruccaE, TomsonT. Progress report on new antiepileptic drugs: a summary of the Eigth Eilat Conference (EILAT VIII).Epilepsy Res.73(1), 1–52 (2007).
  • Meador KJ , LoringDW, AllenMEet al. Comparative cognitive effects of carbamazepine and phenytoin in healthy adults. Neurology 41(10), 1537–1540 (1991).
  • Meador KJ , LoringDW, HulihanJF, KaminM, KarimR. Differential cognitive and behavioral effects of topiramate and valproate.Neurology60(9), 1483–1488 (2003).
  • Aldenkamp AP , De Krom M, Reijs R. Newer antiepileptic drugs and cognitive issues. Epilepsia44(Suppl. 4), 21–29 (2003).
  • Mula M , SanderJW. Negative effects of antiepileptic drugs on mood in patients with epilepsy.Drug Saf.30(7), 555–567 (2007).
  • Olajide D , LaderM. Depression following withdrawal from long-term benzodiazepine use: a report of four cases.Psychol. Med.14(4), 937–940 (1984).
  • Trimble M . Biological Psychiatry (2nd Edition). Wiley, Chichester, UK (1996).
  • Petty F . GABA and mood disorders: a brief review and hypothesis.J. Affect. Disord.34(4), 275–281 (1995).
  • Rodin EA , RimCS, KitanoH, LewisR, RennickPM. A comparison of the effectiveness of primidone versus carbamazepine in epileptic outpatients.J. Nerv. Ment. Dis.163(1), 41–46 (1976).
  • Dodrill CB , TroupinAS. Psychotropic effects of carbamazepine in epilepsy: a double-blind comparison withphenytoin.Neurology27(11), 1023–1028 (1977).
  • Levinson DF , DevinskyO. Psychiatric adverse events during vigabatrin therapy.Neurology53(7), 1503–1511 (1999).
  • Sander JW , HartYM, TrimbleMR, ShorvonSD. Vigabatrin and psychosis.J. Neurol. Neurosurg. Psychiatry54(5), 435–439 (1991).
  • Ring HA , CrellinR, KirkerS, EhR. Vigabatrin and depression.J. Neurol. Neurosurg. Psychiatry56(8), 925–928 (1993).
  • Trimble MR , SchmitzB. Forced Normalization and Alternative Psychoses of Epilepsy. Wrightson Biomedical Publishing Ltd, Petersfield, UK (1998).
  • Thomas L , TrimbleM, SchmitzB, RingH. Vigabatrin and behaviour disorders: a retrospective survey.Epilepsy Res.25(1), 21–27 (1996).
  • Kuzniecky R , HoS, PanJet al. Modulation of cerebral GABA by topiramate, lamotrigine, and gabapentin in healthy adults. Neurology 58(3), 368–372 (2002).
  • Mula M , TrimbleMR, LhatooSD, SanderJW. Topiramate and psychiatric adverse events in patients with epilepsy.Epilepsia44(5), 659–663 (2003).
  • Mula M , HesdorfferDC, TrimbleM, SanderJW. The role of titration schedule of topiramate for the development of depression in patients with epilepsy.Epilepsia50(5), 1072–1076 (2009).
  • Mula M , SanderJW, TrimbleMR. The role of hippocampal sclerosis in antiepileptic drug-related depression in patients with epilepsy: a study on levetiracetam.Seizure15(6), 405–408 (2006).
  • Mula M , TrimbleMR, SanderJW. The role of hippocampal sclerosis in topiramate-related depression and cognitive deficits in people with epilepsy.Epilepsia44(12), 1573–1577 (2003).
  • Mula M , TrimbleMR, SanderJW. Are psychiatric adverse events of antiepileptic drugs a unique entity? A study on topiramate and levetiracetam.Epilepsia48(12), 2322–2326 (2007).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.